Increased utilization of prostate-specific membrane antigen (PSMA)-targeted radionuclide therapy (PSMA-TRT) in African American (AA) patients at an academic medical center.

被引：0
|
作者：
Thomas, Joseph Earl
Nauseef, Jones T.
Sun, Michael Philip
Patel, Amie
Tan, Angela
Bissassar, Mahelia
Manohar, Jyothi
Subramanian, Kritika
Amankwah, Koby
Madera, Gabriela
Molina, Ana M.
Sternberg, Cora N.
Nanus, David M.
Bander, Neil Harrison
Tagawa, Scott T.
机构：
[1] NewYork Presbyterian, Weill Cornell Med Ctr, New York, NY USA
[2] Weill Cornell Med, Div Hematol & Med Oncol, New York, NY USA
[3] Sandra & Edward Meyer Canc Ctr, New York, NY USA
[4] Weill Cornell Med, New York, NY USA
[5] Weill Cornell Med Ctr, New York, NY USA
[6] Weill Cornell Med, Caryl & Israel Englander Inst Precis Med, New York, NY USA
[7] Weill Cornell Med, Div Mol Imaging & Therapeut, Dept Radiol, New York, NY USA
[8] Weill Cornell Med Coll, New York, NY USA
[9] Cornell Univ, Weill Med Coll, NewYork Presbyterian Hosp, New York, NY USA
[10] NewYork Presbyterian Hosp, Englander Inst Precis Med, Weill Cornell Dept Med, Meyer Canc Ctr, New York, NY USA
[11] NewYork Presbyterian Hosp, Div Hematol Med & Oncol, Weill Cornell Med, New York, NY USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2023年 / 41卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
36
引用
收藏
页数：1
相关论文
共 50 条
  • [21] COMPARISON OF PROSTATE-SPECIFIC MEMBRANE ANTIGEN (PSMA)-TARGETED RADIONUCLIDE THERAPY (TRT) WITH LUTETIUM-177 (177LU) VIA ANTIBODY J591 VS SMALL MOLECULE LIGAND PSMA-617
    Niaz, Muhammad Junaid
    Skafida, Myrto
    Osborne, Joseph
    Nanus, David
    Molina, Anna
    Thomas, Charlene
    Vallabhajosula, Shankar
    Christos, Paul
    Bander, Neil
    Tagawa, Scott
    JOURNAL OF UROLOGY, 2020, 203 : E367 - E367
  • [22] Prostate-specific membrane antigen (PSMA) glycoforms in prostate cancer patients seminal plasma
    Mackay, Stephen
    Oduor, Ian O.
    Burch, Tanya C.
    Troyer, Dean A.
    Semmes, Oliver J.
    Nyalwidhe, Julius O.
    PROSTATE, 2024, 84 (05): : 479 - 490
  • [23] MRI Assessment of Prostate-Specific Membrane Antigen (PSMA) Targeting by a PSMA-Targeted Magnetic Nanoparticle: Potential for Image-Guided Therapy
    Ngen, Ethel J.
    Azad, Babak Benham
    Boinapally, Srikanth
    Lisok, Ala
    Brummet, Mary
    Jacob, Desmond
    Pomper, Martin G.
    Banerjee, Sangeeta R.
    MOLECULAR PHARMACEUTICS, 2019, 16 (05) : 2060 - 2068
  • [24] New Strategies in Prostate Cancer: Prostate-Specific Membrane Antigen (PSMA) Ligands for Diagnosis and Therapy
    Haberkorn, Uwe
    Eder, Matthias
    Kopka, Klaus
    Babich, John W.
    Eisenhut, Michael
    CLINICAL CANCER RESEARCH, 2016, 22 (01) : 9 - 15
  • [25] Prostate-Specific Membrane Antigen (PSMA)-Targeted PET Imaging of Prostate Cancer: An Update on Important Pitfalls
    Sheikhbahaei, Sara
    Werner, Rudolf A.
    Solnes, Lilja B.
    Pienta, Kenneth J.
    Pomper, Martin G.
    Gorin, Michael A.
    Rowe, Steven P.
    SEMINARS IN NUCLEAR MEDICINE, 2019, 49 (04) : 255 - 270
  • [26] Pearls and pitfalls in clinical interpretation of prostate-specific membrane antigen (PSMA)-targeted PET imaging
    Sara Sheikhbahaei
    Ali Afshar-Oromieh
    Matthias Eiber
    Lilja B. Solnes
    Mehrbod S. Javadi
    Ashley E. Ross
    Kenneth J. Pienta
    Mohamad E. Allaf
    Uwe Haberkorn
    Martin G. Pomper
    Michael A. Gorin
    Steven P. Rowe
    European Journal of Nuclear Medicine and Molecular Imaging, 2017, 44 : 2117 - 2136
  • [27] Pearls and pitfalls in clinical interpretation of prostate-specific membrane antigen (PSMA)-targeted PET imaging
    Sheikhbahaei, Sara
    Afshar-Oromieh, Ali
    Eiber, Matthias
    Solnes, Lilja B.
    Javadi, Mehrbod S.
    Ross, Ashley E.
    Pienta, Kenneth J.
    Allaf, Mohamad E.
    Haberkorn, Uwe
    Pomper, Martin G.
    Gorin, Michael A.
    Rowe, Steven P.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2017, 44 (12) : 2117 - 2136
  • [28] Baseline and post-treatment circulating tumor cell (CTC) counts with prostate-specific membrane antigen (PSMA)-targeted radionuclide therapy (TRT) in men with metastatic castration-resistant prostate cancer (mCRPC).
    Sun, Michael
    Lebenthal, Justin M.
    Nauseef, Jones T.
    Niaz, Muhammad Junaid
    Guervil, Sabrina
    Fernandez, Escarleth
    Patel, Amie
    Tan, Angela
    Vlachostergios, Panagiotis J.
    Osborne, Joseph
    Molina, Ana M.
    Sternberg, Cora N.
    Nanus, David M.
    Bander, Neil Harrison
    Tagawa, Scott T.
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (06)
  • [29] Prostate-specific membrane antigen (PSMA) immunoexpression in the neovasculature of colorectal carcinoma in,Egyptian patients
    Abdel-Hadi, Mona
    Ismail, Yasser
    Younis, Layla
    PATHOLOGY RESEARCH AND PRACTICE, 2014, 210 (11) : 759 - 763
  • [30] Dosimetry in Lu-177-PSMA-617 prostate-specific membrane antigen targeted radioligand therapy: a systematic review
    Nautiyal, Amit
    Jha, Ashish K.
    Mithun, Sneha
    Rangarajan, Venkatesh
    NUCLEAR MEDICINE COMMUNICATIONS, 2022, 43 (04) : 369 - 377
12345